Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05725317 · ClinicalTrials.gov registry record · NA
Clinical Performance Assessment of Two Silicone Hydrogel Daily Disposable Contact Lenses
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 114
- Enrollment target
NCT05725317: Completed NA study, sponsored by Alcon Research.
NCT05725317 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 114 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05725317, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 114 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the overall clinical performance of a contact lens made with a modified manufacturing process.
Primary Outcome
VA was assessed for each eye individually at a distance of 4 meters with contact lenses in place using a letter chart. VA was measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity.
Interventions
- DEVICE LID220365 contact lens
- DEVICE LID006961 contact lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2023-06-02 |
| Est. Completion | 2023-06-27 |
| Phase | NA |
What the finished NCT05725317 record still lists
NCT05725317 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which LID220365 contact lens is the first listed.
NCT05725317 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05725317 about?
NCT05725317 is a clinical study titled "Clinical Performance Assessment of Two Silicone Hydrogel Daily Disposable Contact Lenses". The purpose of this study is to assess the overall clinical performance of a contact lens made with a modified manufacturing process.
What is the current status of trial NCT05725317?
This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2023-06-02. Estimated completion is 2023-06-27.
What interventions are being tested in trial NCT05725317?
The interventions under investigation include: LID220365 contact lens (DEVICE), LID006961 contact lens (DEVICE).
Who is sponsoring clinical trial NCT05725317?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05725317's enrollment target sits among peer trials
114 811th of 2000 higher than 1,188 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI